SCHEMBL7693169

SCHEMBL7693169

CCCCC(NC(=O)c1ccccc1C=Cc1ccc(CN2CCCC2)cc1)C(=O)CNC(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 7/20 0.53
CTSB P07858 5/20 0.53
CTSS P25774 2/20 0.42
CTSK P43235 2/20 0.42
CTSL P07711 2/20 0.41
CCR2 P41597 1/20 0.39
BCHE P06276 4/20 0.39
ACHE P22303 4/20 0.39
CACNA1F O60840 1/20 0.39
CACNA1D Q01668 1/20 0.39
CACNA1S Q13698 1/20 0.39
CACNA1C Q13936 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
CTSD P07339 1/20 0.39
HDAC1 Q13547 3/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690557 0.99 CAPN1 (0.52) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693664 0.96 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693292 0.95 CAPN1 (0.46) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7691143 0.94 CAPN1 (0.54) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7695354 0.94 CAPN1 (0.46) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7694279 0.94 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696093 0.92 CAPN1 (0.54) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7691340 0.91 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7691476 0.91 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7694302 0.89 CAPN1 (0.47) CAPN1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed